Background: Leadless pacemakers (LPM) are introduced in cardiovascular market with a goal to avoid lead- and pocket-associated complications due to conventional artificial pacemakers (CPM). The comparison of LPM and CPM complications is not well studied at a case by case
Heart failure (HF) is the fourth-most frequent cause of death and remains a challenge for public health. Therapy goals for HF with reduced ejection fraction (HFrEF) are the improvement in the quality of life, prolonged survival, a reduction of signs
The blog post “Improving Research͏ Synthesis with Meta-Analysis: L͏ess͏ons from Axeusce.com” explain how Axeusce.c͏om is dedica͏ted to ͏enh͏ancing researc͏h synthesi͏s using adva͏nced m͏eta-͏analy͏tical m͏ethods like Mean Inverse͏ Variance Meta-Analysis, Propo͏rtional Meta-An͏alysis, Adva͏nced Net͏wor͏k Meta-Analysis, Diagno͏stic Accuracy Meta-Analysis, and their inclusion
Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic that may present with a variety of cardiac manifestations including, but not limited to, myocardial injury, myocardial infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest. These cardiovascular effects
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a condition caused by the replacement of the normal right ventricular myocardium with fibrofatty tissue. ARVC/D can present with a variety of clinical conditions including right ventricular dysfunction, ventricular tachyarrhythmias, sudden cardiac arrest, and